Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2025-05-05
DOI
https://doi.org/10.1186/s12916-025-04103-0
Citations
3
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
5.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial

Qingqing Cai, Yingxian Liu, Tsao‐Cheng Huang, Yi Cao et al.
3 citations
BMC Medicine
Head and Neck Cancer Studies
5.54
article

Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial

Qingqing Cai, Yingxian Liu, Tsao‐Cheng Huang, Yi Cao, Lixia Lu, Ning Su, Zhihua Li, Panpan Liu, Yuchen Zhang, Lirong Li, Fang Yu, Xicheng Wang, Xiaopeng Tian, Yi Xia, Qihua Zou, Y.C. Lai, Hao Wu
article en
3 citations

Abstract

No abstract available for this paper.
BMC MedicineVol. 23(1)
Sun Yat-sen University (CN), Sun Yat-sen Memorial Hospital (CN), Sun Yat-sen University Cancer Center (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 4%
Head and Neck Cancer Studies
5.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial — Qingqing Cai, Yingxian Liu, et al. · BMC Medicine (2025) | TGRS Research Map | TGRS